Dopamine receptor agonists: new angularly annulated tricyclic compounds
Perrone, R.; Berardi, F.; Bettoni, G.; Tortorella, V.
Il Farmaco; Edizione Scientifica 43(1): 61-69
1988
ISSN/ISBN: 0430-0920 PMID: 3396689 Document Number: 321899
In order to study the influence on dopaminergic activity of the exchange of X in rigid dopamine congeners of structure 1, the synthesis of octahydrobenzo thiazines (X c, d), is reported.
Document emailed within 1 workday
Related Documents
Kohli, J.D. 1990: Dopamine receptor agonists and antagonists Proceedings of the Western Pharmacology Society 33: 21-27Woolverton, W.L.; Goldberg, L.I.; Ginos, J.Z. 1984: Intravenous self-administration of dopamine receptor agonists by rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 230(3): 678-683
Perrone, R.; Berardi, F.; Bettoni, G.; Tortorella, V. 1988: Synthesis of new linearly annulated tricycles as rigid dopamine congeners Il Farmaco; Edizione Scientifica 43(1): 71-77
Imperato, A.; Tanda, G.; Frau, R.; Di Chiara, G. 1988: Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats Journal of Pharmacology and Experimental Therapeutics 245(1): 257-264
Seiler, S.M.; Peluso, M.; Tuttle, J.G.; Pryor, K.; Klimas, C.; Matsueda, G.R.; Bernatowicz, M.S. 1996: Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists Molecular Pharmacology 49(1): 190-197
Parfitt, K.D.; Gratton, A.; Bickford-Wimer, P.C. 1990: Electrophysiological effects of selective D1 and D2 dopamine receptor agonists in the medial prefrontal cortex of young and aged Fischer 344 rats Journal of Pharmacology and Experimental Therapeutics 254(2): 539-545
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Kohli, J.D.; Weder, A.B.; Goldberg, L.I.; Ginos, J.Z. 1980: Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors Journal of Pharmacology and Experimental Therapeutics 213(2): 370-374
Breese, G.R.; Baumeister, A.A.; McCown, T.J.; Emerick, S.G.; Frye, G.D.; Crotty, K.; Mueller, R.A. 1984: Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine Journal of Pharmacology and Experimental Therapeutics 231(2): 343-354
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446
Molnár, J. 1988: Antiplasmid activity of tricyclic compounds Methods and Findings in Experimental and Clinical Pharmacology 10(7): 467-474
Tanji, H.; Nagasawa, H.; Itoh, M.; Itoyama, Y. 1997: PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism Nihon Rinsho. Japanese Journal of Clinical Medicine 55(1): 89-94
Pirtosek, Z.; Flisar, D. 2004: Neuroprotection and dopamine agonists Advances in Experimental Medicine and Biology 541: 55-74
Heins, J.R. 1997: New dopamine agonists on the horizon South Dakota Journal of Medicine 50(7): 239-240
Hillegaart, V.; Ahlenius, S.; Fowler, C.J.; Magnusson, O. 1988: Increased duration of dopamine receptor antagonist-induced effects on both behaviour and striatal dopamine turnover by repeated testing in rats Pharmacology and Toxicology 63(2): 114-117
Zarifian, E. 1979: Dopa and dopamine agonists in depression L'Encephale 5(5 Suppl): 665-670
Teräväinen, H.; Calne, S.; Burton, K.; Beckman, J.; Calne, D.B. 1988: Efficacy of dopamine agonists in dystonia Advances in Neurology 50: 571-578
Waligóra, B.; Grabowska, A. 1973: Adsorption of tricyclic compounds of dibenzazepine and dibenzcycloheptadiene type on the water-air interface Polish Journal of Pharmacology and Pharmacy 25(2): 207-215
Kurzawa, M.; Dembiński, B.; Szydłowska-Czerniak, A.; Sandra, P. 1999: Quantitative determination of selected tricyclic biological active compounds by using capillary electrophoresis Acta Poloniae Pharmaceutica 56(6): 415-417
Gekht, A.B. 2002: Use of dopamine agonists in the treatment of Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 102(9): 54-58